Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo

CHE-MING TENG2018-09-102018-09-102015http://www.scopus.com/inward/record.url?eid=2-s2.0-84924964704&partnerID=MN8TOARShttp://scholars.lib.ntu.edu.tw/handle/123456789/392039Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivojournal article